Ubiquigent Competitors and Similar CompaniesClear all

Ubiquigent's competitors and similar companies include Genentech, Ipsen and Vertex Pharmaceuticals.

	Ubiquigent Ubiquigent is a biotech company providing drug discovery services to the research community.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Ipsen Ipsen is a biopharmaceutical company.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
Founding Date	Founding Date 2009	Founding Date 1976	Founding Date 1929	Founding Date 1989
Type	Type Private	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Dundee, GB HQ Dundee, GB	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more
Employees	Employees 713% decrease	Employees 18,077	Employees 5,358	Employees 5,40013% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 10.2 b	Valuation ($) 121.4 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €3.7b (FY, 2025)	Revenue (est.) $12b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods €659.1m (FY, 2025)	Cost of goods $1.7b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit €3.3b (FY, 2025)	Gross profit $10.4b (FY, 2025)
Funding
Total funding raised	Total funding raised $ 795.1k	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 2.4m